Isabella Hornick is an Editorial Assistant at Environmental Post Ledger. She specializes in a variety of themes including medicine and healthcare, public health, and wellness, with a focus on topics such as patient care, mental health care, and healthcare technology. Isabella's work has been featured in Environmental Post Ledger and Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Isabella's articles predominantly focus on pulmonology, with a strong emphasis on citing data. To effectively reach out to her, consider providing well-researched and fact-based insights related to topics such as pulmonology, sleep disorders, respiratory health, and lung-related conditions backed by recent data or studies.
Given the scientific nature of Isabella's coverage, she may be interested in receiving pitches from experts in the field who can provide detailed analysis or commentary based on credible research findings. Additionally, considering the prevalence of COVID-19 stories in her articles, offering new developments or significant studies related to COVID-19 within the scope of pulmonology could also capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kristen Dowd, Isabella Hornick
After receiving a short course of omalizumab, 97% of patients started daily oral immunotherapy maintenance dosing for at least one of their food allergens, according to data published in Annals of Allergy, Asthma & Immunology
By: Kristen Dowd, Isabella Hornick
In U.S. areas with a high prevalence of alpha-gal syndrome, patients with blood type O who received B or AB vs.
By: Kristen Dowd, Isabella Hornick
Adults with both obstructive sleep apnea and insomnia vs. only obstructive sleep apnea had larger decreases in 24-hour, daytime and nocturnal systolic blood pressure following 4 weeks of CPAP, according to data published in CHEST
By: Isabella Hornick
The risks for various adverse maternal and neonatal outcomes did not significantly differ between women who continued inhaled corticosteroid use in the first trimester and women who did not, according to data published in JAMA Network Open.“These findings provide reassuring evidence supporting current guideline recommendations to continue ICS therapy during pregnancy and highlight the
By: Kristen Dowd, Isabella Hornick, Ricardo A. Mosquera
Through a clinic in Mexico, Ricardo A. Mosquera MD, is helping an underrepresented population in the realm of primary ciliary dyskinesia get diagnosed, treated and involved in rare lung disease research.
By: Isabella Hornick, Kristen Dowd
Adolescents and adults with eosinophilic esophagitis receiving tezepelumab vs. placebo had improved frequency and severity of dysphagia and more
By: Kristen Dowd, Isabella Hornick
The odds for clinical remission achievement in patients with type 2 inflammatory severe asthma were greater with dupilumab vs. other biologics, according
By: Isabella Hornick, Kristen Dowd
In Allergy, Asthma & Clinical Immunology articles published between 2011 and 2023, a similar proportion of women and men were first authors, but a smaller proportion of women were last authors, according to study data.
By: Isabella Hornick, Kristen Dowd
In European school children, a link emerged between two bacteria in classroom dust — Streptomyces and Mycobacterium spp. — and lower lung
By: Isabella Hornick, Kristen Dowd
The California Department of Public Health identified 592 cases of “especially severe” engineered stone silicosis in workers between January 2019 and June 2026, according to findings published in NEJM Evidence
